A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
PurposeThe present study aimed to develop and validate a preoperative model based on gadobenate-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) size of ≤5 cm. In order to provide preoperative guidance for clinician...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.992301/full |
_version_ | 1811285716385136640 |
---|---|
author | Sisi Zhang Lei Huo Juan Zhang Yayuan Feng Yiping Liu Yuxian Wu Ningyang Jia Wanmin Liu |
author_facet | Sisi Zhang Lei Huo Juan Zhang Yayuan Feng Yiping Liu Yuxian Wu Ningyang Jia Wanmin Liu |
author_sort | Sisi Zhang |
collection | DOAJ |
description | PurposeThe present study aimed to develop and validate a preoperative model based on gadobenate-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) size of ≤5 cm. In order to provide preoperative guidance for clinicians to optimize treatment options.Methods164 patients with pathologically confirmed HCC and preoperative gadobenate-enhanced MRI from July 2016 to December 2020 were retrospectively included. Univariate and multivariate logistic regression (forward LR) analyses were used to determine the predictors of MVI and the model was established. Four-fold cross validation was used to verify the model, which was visualized by nomograms. The predictive performance of the model was evaluated based on discrimination, calibration, and clinical utility.ResultsElevated alpha-fetoprotein (HR 1.849, 95% CI: 1.193, 2.867, P=0.006), atypical enhancement pattern (HR 3.441, 95% CI: 1.523, 7.772, P=0.003), peritumoral hypointensity on HBP (HR 7.822, 95% CI: 3.317, 18.445, P<0.001), and HBP hypointensity (HR 3.258, 95% CI: 1.381, 7.687, P=0.007) were independent risk factors to MVI and constituted the HBP model. The mean area under the curve (AUC), sensitivity, specificity, and accuracy values for the HBP model were as follows: 0.830 (95% CI: 0.784, 0.876), 0.71, 0.78, 0.81 in training set; 0.826 (95% CI:0.765, 0.887), 0.8, 0.7, 0.79 in test set. The decision curve analysis (DCA) curve showed that the HBP model achieved great clinical benefits.ConclusionIn conclusion, the HBP imaging features of Gd-BOPTA-enhanced MRI play an important role in predicting MVI for HCC. A preoperative model, mainly based on HBP imaging features of gadobenate-enhanced MRI, was able to excellently predict the MVI for HCC size of ≤5cm. The model may help clinicians preoperatively assess the risk of MVI in HCC patients so as to guide clinicians to optimize treatment options. |
first_indexed | 2024-04-13T02:48:12Z |
format | Article |
id | doaj.art-fa96a5c8063642858d30cec7344dd0e6 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-13T02:48:12Z |
publishDate | 2022-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-fa96a5c8063642858d30cec7344dd0e62022-12-22T03:05:56ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.992301992301A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)Sisi Zhang0Lei Huo1Juan Zhang2Yayuan Feng3Yiping Liu4Yuxian Wu5Ningyang Jia6Wanmin Liu7Department of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaPurposeThe present study aimed to develop and validate a preoperative model based on gadobenate-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) size of ≤5 cm. In order to provide preoperative guidance for clinicians to optimize treatment options.Methods164 patients with pathologically confirmed HCC and preoperative gadobenate-enhanced MRI from July 2016 to December 2020 were retrospectively included. Univariate and multivariate logistic regression (forward LR) analyses were used to determine the predictors of MVI and the model was established. Four-fold cross validation was used to verify the model, which was visualized by nomograms. The predictive performance of the model was evaluated based on discrimination, calibration, and clinical utility.ResultsElevated alpha-fetoprotein (HR 1.849, 95% CI: 1.193, 2.867, P=0.006), atypical enhancement pattern (HR 3.441, 95% CI: 1.523, 7.772, P=0.003), peritumoral hypointensity on HBP (HR 7.822, 95% CI: 3.317, 18.445, P<0.001), and HBP hypointensity (HR 3.258, 95% CI: 1.381, 7.687, P=0.007) were independent risk factors to MVI and constituted the HBP model. The mean area under the curve (AUC), sensitivity, specificity, and accuracy values for the HBP model were as follows: 0.830 (95% CI: 0.784, 0.876), 0.71, 0.78, 0.81 in training set; 0.826 (95% CI:0.765, 0.887), 0.8, 0.7, 0.79 in test set. The decision curve analysis (DCA) curve showed that the HBP model achieved great clinical benefits.ConclusionIn conclusion, the HBP imaging features of Gd-BOPTA-enhanced MRI play an important role in predicting MVI for HCC. A preoperative model, mainly based on HBP imaging features of gadobenate-enhanced MRI, was able to excellently predict the MVI for HCC size of ≤5cm. The model may help clinicians preoperatively assess the risk of MVI in HCC patients so as to guide clinicians to optimize treatment options.https://www.frontiersin.org/articles/10.3389/fonc.2022.992301/fullgadobenate dimegluminehepatocellular carcinomamicrovascular invasionmagnetic resonance imagingnomogram |
spellingShingle | Sisi Zhang Lei Huo Juan Zhang Yayuan Feng Yiping Liu Yuxian Wu Ningyang Jia Wanmin Liu A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm) Frontiers in Oncology gadobenate dimeglumine hepatocellular carcinoma microvascular invasion magnetic resonance imaging nomogram |
title | A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm) |
title_full | A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm) |
title_fullStr | A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm) |
title_full_unstemmed | A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm) |
title_short | A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm) |
title_sort | preoperative model based on gadobenate enhanced mri for predicting microvascular invasion in hepatocellular carcinomas ≤ 5 cm |
topic | gadobenate dimeglumine hepatocellular carcinoma microvascular invasion magnetic resonance imaging nomogram |
url | https://www.frontiersin.org/articles/10.3389/fonc.2022.992301/full |
work_keys_str_mv | AT sisizhang apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT leihuo apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT juanzhang apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT yayuanfeng apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT yipingliu apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT yuxianwu apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT ningyangjia apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT wanminliu apreoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT sisizhang preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT leihuo preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT juanzhang preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT yayuanfeng preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT yipingliu preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT yuxianwu preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT ningyangjia preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm AT wanminliu preoperativemodelbasedongadobenateenhancedmriforpredictingmicrovascularinvasioninhepatocellularcarcinomas5cm |